These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


452 related items for PubMed ID: 10373130

  • 1. Improved outcome of acute myeloid leukaemia in Down's syndrome.
    Craze JL, Harrison G, Wheatley K, Hann IM, Chessells JM.
    Arch Dis Child; 1999 Jul; 81(1):32-7. PubMed ID: 10373130
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO).
    Lie SO, Jonmundsson G, Mellander L, Siimes MA, Yssing M, Gustafsson G.
    Br J Haematol; 1996 Jul; 94(1):82-8. PubMed ID: 8757513
    [Abstract] [Full Text] [Related]

  • 5. Prognosis of Down's syndrome with acute leukaemia.
    Levitt GA, Stiller CA, Chessells JM.
    Arch Dis Child; 1990 Feb; 65(2):212-6. PubMed ID: 2138446
    [Abstract] [Full Text] [Related]

  • 6. Megakaryoblastic leukemia and Down's syndrome: a review.
    Zipursky A, Peeters M, Poon A.
    Pediatr Hematol Oncol; 1987 Feb; 4(3):211-30. PubMed ID: 2978961
    [Abstract] [Full Text] [Related]

  • 7. An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.
    Kojima S, Sako M, Kato K, Hosoi G, Sato T, Ohara A, Koike K, Okimoto Y, Nishimura S, Akiyama Y, Yoshikawa T, Ishii E, Okamura J, Yazaki M, Hayashi Y, Eguchi M, Tsukimoto I, Ueda K.
    Leukemia; 2000 May; 14(5):786-91. PubMed ID: 10803507
    [Abstract] [Full Text] [Related]

  • 8. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
    Gamis AS, Woods WG, Alonzo TA, Buxton A, Lange B, Barnard DR, Gold S, Smith FO, Children's Cancer Group Study 2891.
    J Clin Oncol; 2003 Sep 15; 21(18):3415-22. PubMed ID: 12885836
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Down's Syndrome-Transient Abnormal Myelopoiesis and Acute Leukaemia.
    Bain B.
    Leuk Lymphoma; 1991 Sep 15; 3(5-6):309-17. PubMed ID: 27467421
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials.
    Lie SO, Abrahamsson J, Clausen N, Forestier E, Hasle H, Hovi L, Jonmundsson G, Mellander L, Gustafsson G.
    Br J Haematol; 2003 Jul 15; 122(2):217-25. PubMed ID: 12846889
    [Abstract] [Full Text] [Related]

  • 18. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis.
    Fong CT, Brodeur GM.
    Cancer Genet Cytogenet; 1987 Sep 15; 28(1):55-76. PubMed ID: 2955886
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.